Glaucoma is a progressive optical neuropathy, generally associated with ocular hypertension.
The treatment aims to stabilize the visual field deficiencies by lowering the intraocular
pressure. Due to the fluctuation of the visual field test and re-test measures, the European
recommendations are to obtain 6 visual field tests in 2 years (or one every 4 months) in
order to know if the pathology is progressing despite the current treatment (or if the
treatment is necessary, in cases of intraocular hypertensions). The lack of ophthalmologists
renders the monitoring of a beginning glaucoma, rarely compatible with the present
recommendations. It is therefore crucial to evaluate new therapeutic alternatives, when faced
to a decreasing medical demography and an increase the patient's needs.
This study should allow to validate the possibility to delegate monitoring tasks to
orthoptists during glaucoma surveillance. To organize the delegation of this surveillance to
orthoptists would permit a better distribution of the ophthalmologist's activities.